SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001683168-24-002589
Filing Date
2024-04-22
Accepted
2024-04-22 17:05:39
Documents
7
Period of Report
2024-06-17

Document Format Files

Seq Description Document Type Size
1 PRELIMINARY PROXY STATEMENT phio_pre14a.htm PRE 14A 480432
2 GRAPHIC image_001.jpg GRAPHIC 2140
3 GRAPHIC image_002.jpg GRAPHIC 2129
4 GRAPHIC image_003.jpg GRAPHIC 10260
5 GRAPHIC image_004.jpg GRAPHIC 11696
6 GRAPHIC image_005.jpg GRAPHIC 168531
7 GRAPHIC image_006.jpg GRAPHIC 120610
  Complete submission text file 0001683168-24-002589.txt   916682
Mailing Address 11 APEX DRIVE, SUITE 300A PMB 2006 MARLBOROUGH MA 01752
Business Address 11 APEX DRIVE, SUITE 300A PMB 2006 MARLBOROUGH MA 01752 (508) 767-3861
Phio Pharmaceuticals Corp. (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-36304 | Film No.: 24861930
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)